Janux Therapeutics Inc
JANX
Market Cap$2.45B
Close$
$-0.94
102% downside
Current Fair Value
102% downsideOvervalued by 102% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.45 Billion |
|---|---|
| Enterprise Value | $2.13 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.32 |
| Beta | 0.0 |
| Outstanding Shares | 51,660,060 |
| Avg 30 Day Volume | 853,005 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -42.0 |
|---|---|
| PEG | 285.25 |
| Price to Sales | - |
| Price to Book Ratio | 7.9 |
| Enterprise Value to Revenue | 263.35 |
| Enterprise Value to EBIT | -29.17 |
| Enterprise Value to Net Income | -37 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
ESG Score
No data
About Janux Therapeutics Inc
16 employees